On September 9, the U.S. Court of Appeals for the District of
a temporary injunction barring the federal government from funding research
involving human embryonic stem cell research (hESC).
The court granted a request from
the Department of Justice (DOJ) to stay an injunction issued
August 23 which blocked the federal funding of hESC research. The Justice
Department argued the judge’s ruling will cause irreparable harm to
researchers, taxpayers and scientific progress. As part of its ruling, the
court indicated that the Obama Administration could resume funding the research
pending a full appeal of the case. This means that the National Institutes of
Health (NIH) can, at least temporarily, resume both its intramural hESC
research and its normal extramural application and grant processes.
The following statement was
released by the NIH today:
are pleased with the Court's interim ruling, which will allow promising stem
cell research to continue while we present further arguments to the Court in
the weeks to come. With the temporary stay in place, NIH has resumed intramural
research and will continue its consideration of grants that were frozen by the
preliminary injunction on August 23. The suspension of all grants, contracts,
and applications that involve the use of human embryonic stem cells has been
temporarily lifted. Human embryonic stem cell research holds the potential for
generating profound new insights into disease, cell-based therapeutics, and
novel methods of screening for new drugs."
will continue to monitor and provide updates on all developments on this issue.
back to top